Sangamo Therapeutics, Inc
SGMOQ- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001001233
No open-market purchases or sales by Sangamo Therapeutics, Inc insiders were filed in the last 90 days; 6 institutions reported holding it in 13F filings for Q2 2026, worth $29.0K in total; no superinvestor holds it.
13F holders, Q3 2025
Institutional positions in Sangamo Therapeutics, Inc as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 112
- −1 vs. Q2 2025
- Shares held
- 62.6M
- −10.6M (−14.5%) vs. Q2 2025
- Total value
- $42.1M
- +$2.52M (+6.3%) vs. Q2 2025
- New holders
- 18
- 39 more added
- Sold out
- 19
- 17 more reduced
1 institution that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SGMOQ on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 6 | $29.0K |
| Q1 2026 | 112 | $26.0M |
| Q4 2025 | 105 | $26.2M |
| Q3 2025 | 112 | $42.1M |
| Q2 2025 | 114 | $39.6M |
| Q1 2025 | 122 | $34.5M |
| Q4 2024 | 128 | $62.9M |
| Q3 2024 | 103 | $48.6M |
| Q2 2024 | 129 | $31.1M |
| Q1 2024 | 131 | $68.2M |
| Q4 2023 | 130 | $47.2M |
| Q3 2023 | 135 | $61.3M |
| Q2 2023 | 152 | $137.4M |
| Q1 2023 | 180 | $197.6M |
| Q4 2022 | 182 | $326.0M |
| Q3 2022 | 197 | $477.2M |
| Q2 2022 | 188 | $371.1M |
| Q1 2022 | 195 | $459.6M |
| Q4 2021 | 193 | $577.0M |
| Q3 2021 | 193 | $679.3M |
| Q2 2021 | 197 | $912.0M |
| Q1 2021 | 203 | $994.7M |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Sangamo Therapeutics, Inc; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| State Street Corp | 1,355,583 | $912.9K | 0.00% | +519,131+62.1% | Added |
| Wasatch Advisors Inc | 1,426,453 | $960.6K | 0.01% | −6,657,966−82.4% | Reduced |
| Charles Schwab Investment Management Inc | 1,538,998 | $1.04M | 0.00% | +257,199+20.1% | Added |
| Two Sigma Advisers, LP | 2,108,355 | $1.42M | 0.00% | +901,621+74.7% | Added |
| Jane Street Group, LLC | 2,200,685 | $1.48M | 0.00% | +2,200,685 | New |
| Susquehanna International Group, LLP | 2,420,366 | $1.63M | 0.00% | +1,647,100+213.0% | Added |
| Two Sigma Investments, LP | 2,479,186 | $1.67M | 0.00% | +1,602,107+182.7% | Added |
| Geode Capital Management, LLC | 3,286,476 | $2.21M | 0.00% | +954,197+40.9% | Added |
| Gsa Capital Partners LLP | 3,662,478 | $2.47M | 0.21% | +1,417,029+63.1% | Added |
| BlackRock, Inc. | 4,556,208 | $3.07M | 0.00% | −252,500−5.3% | Reduced |
| Renaissance Technologies LLC | 10,182,463 | $6.86M | 0.01% | +3,343,029+48.9% | Added |
| Vanguard Group Inc | 11,615,150 | $7.82M | 0.00% | +2,240,422+23.9% | Added |
| Yorkville Advisors Global, LP | 0 | $0 | 0.00% | −22,000,000−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −625,034−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −205,170−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −187,395−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −76,413−100.0% | Sold out |
| International Assets Investment Management, LLC | 0 | $0 | 0.00% | −34,000−100.0% | Sold out |
| Franklin Resources Inc | 0 | $0 | 0.00% | −16,594−100.0% | Sold out |
| Raymond James Financial Inc | 0 | $0 | 0.00% | −15,544−100.0% | Sold out |
| Kestra Advisory Services, LLC | 0 | $0 | 0.00% | −14,643−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −13,921−100.0% | Sold out |
| Davenport & Co LLC | 0 | $0 | 0.00% | −13,500−100.0% | Sold out |
| Fort Sheridan Advisors LLC | 0 | $0 | 0.00% | −12,723−100.0% | Sold out |
| Family Legacy Financial Solutions, LLC | 0 | $0 | 0.00% | −3,802−100.0% | Sold out |
| UMA Financial Services, Inc. | 0 | $0 | 0.00% | −1,271−100.0% | Sold out |
| Transce3nd, LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Twin Peaks Wealth Advisors, LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Albion Financial Group | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −139−100.0% | Sold out |
| Caitong International Asset Management Co., Ltd | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| PrairieView Partners, LLC | – | – | – | – | Not filed |